Reactive Microglia in Creutzfeldt-Jakob Disease
Overview
Authors
Affiliations
Creutzfeldt-Jakob disease (CJD) is characterized by a loss of neurons accompanied by astrogliosis and spongiform changes in the neuropil. It has been recognized that reactive microglia occur in CJD but little is known about the regional distribution and extent of the microglial activation. We have, therefore, examined six brains from cases of sporadic CJD by immunohistochemical labelling of grey and white matter microglia from frontal, parietal, temporal, and occipital lobes, striatum, thalamus, cerebellum and brain stem with RCA-1, LCA, CD68, HLA-DR, and HAM56. Microglial activation occurred in the grey matter where astrogliosis and prion protein (PrP) deposits were prominent. Processes of activated microglia surrounded the outer rim of spongy vacuoles. A diffuse microglial response was seen in the white matter that was immunophenotypically different from grey matter. Double-labelling with microglial markers and anti-PrP showed that activated microglia did not contain PrP-immunoreactivity. Therefore a primary role of microglia in PrP processing seems unlikely. Activated microglia may contribute to neuronal damage in CJD due to their cytotoxic potential.
The Neuroimmune System and the Cerebellum.
Gruol D Cerebellum. 2023; 23(6):2511-2537.
PMID: 37950146 PMC: 11585519. DOI: 10.1007/s12311-023-01624-3.
Adipose-derived mesenchymal stromal cells decrease prion-induced glial inflammation in vitro.
Hay A, Murphy T, Popichak K, Zabel M, Moreno J Sci Rep. 2022; 12(1):22567.
PMID: 36581683 PMC: 9800558. DOI: 10.1038/s41598-022-26628-7.
The multiple functions of PrP in physiological, cancer, and neurodegenerative contexts.
Grimaldi I, Leser F, Janeiro J, da Rosa B, Campanelli A, Romao L J Mol Med (Berl). 2022; 100(10):1405-1425.
PMID: 36056255 DOI: 10.1007/s00109-022-02245-9.
Neuroinflammation in Prion Disease.
Li B, Chen M, Zhu C Int J Mol Sci. 2021; 22(4).
PMID: 33672129 PMC: 7926464. DOI: 10.3390/ijms22042196.
Microglia in Prion Diseases: Angels or Demons?.
Peggion C, Stella R, Lorenzon P, Spisni E, Bertoli A, Massimino M Int J Mol Sci. 2020; 21(20).
PMID: 33092220 PMC: 7589037. DOI: 10.3390/ijms21207765.